EUVIMEDEUVIMED entdecken
Crossref

Ultrasound‐Responsive Macrophage Biomimetic Phase‐Change Nanoparticles for Delivering miR‐126 Ameliorate Murine Heart Transplant Rejection

Haichao Yang, Haobo Yang, Jinhong Liu, Jianfeng Chen, Cong Liu, Jiaxu Wang, Jiaxin Shan, Mingyuan Xu, Guangyin Li, Yuan Yao, Sirui Tian, Chen Zhao und 7 weitere

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202505516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Haichao Yang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, the First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: MicroRNAs, Nanoparticles, Heart Transplantation, Macrophages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Key Research and Development Programme of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rejection following heart transplantation remains a significant challenge in the medical science. In addition to the immune response, the inflammatory response and microvascular endothelial damage can exacerbate rejection; however, current therapies focus primarily on the immune response. Numerous studies have confirmed that miR‐126 regulates vascular inflammation and promotes angiogenesis. To achieve the precise targeted delivery of miR‐126, macrophage biomimetic ultrasound phase‐change cationic nanoparticles carrying miR‐126 (miR‐126‐MCNPs) are synthesized. Incorporation of the macrophage membrane enhances the anti‐phagocytic and inflammatory targeting of nanoparticles, thereby prolonging the circulation time and promoting aggregation in the transplanted heart. Using ultrasound‐targeted microbubble destruction (UTMD), the perfluoropentane nanoparticle core undergoes a phase change in the ultrasound irradiation zone, allowing the targeted delivery of macrophage membranes and miR‐126, and significantly improving the transfection efficiency of the miR‐126. Consequently, anti‐inflammatory effects are achieved, such as inhibition of macrophage and CD3 + T cells infiltration, and alteration of M2‐type macrophage differentiation. In addition, this study demonstrates that the combination of miR‐126‐MCNPs with UTMD can alleviate the extent of vascular endothelial and interstitial fibrosis in transplanted hearts, increase angiogenesis, and improve microcirculation and cardiac function. This research provides a new strategy for the precision‐targeted therapy of cardiac transplant rejection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNanoparticlesHeart TransplantationMacrophagesGraft RejectionBiomimetic MaterialsAnimalsMiceMicrobubblesRAW 264.7 CellsFluorocarbonsMice, Inbred BALB CMalePentanes

Stichwörter der Autor:innen

heart transplantmacrophage biomimetic nanoparticlesultrasound phase‐changeultrasound‐targeted microbubble destruction

Substanzen

MicroRNAsMIRN126 microRNA, mouseperfluoropentaneFluorocarbonsPentanes

Autor:innen und Institutionen

  • Department of Ultrasound, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Department of Ultrasound, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Ultrasound molecular imaging Joint laboratory of Heilongjiang province (International Cooperation), Harbin, China.
  • Key Laboratories of Myocardial Ischemia Mechanism and Treatment, Harbin Medical University, Ministry of Education, Harbin, China.
  • Department of Magnetic Resonance Diagnosis, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.

ORCID-Profile: Xiaoping Leng

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Key Research and Development Programme of Heilongjiang Province
  • The Fundamental Research Funds for The Provincial Universities in Heilongjiang Province
  • Heilongjiang Provincial Postdoctoral Science Foundation

Zitieren

APA

Yang, H., Yang, H., Liu, J., Chen, J., Liu, C., Wang, J., Shan, J., Xu, M., Li, G., Yao, Y., Tian, S., Zhao, C., Zhang, T., Yin, L., Tao, Y., Yu, D., Li, S., Wang, Z., & Leng, X. (2026). Ultrasound‐Responsive Macrophage Biomimetic Phase‐Change Nanoparticles for Delivering miR‐126 Ameliorate Murine Heart Transplant Rejection. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505516

Vancouver

Yang H, Yang H, Liu J, Chen J, Liu C, Wang J, et al. Ultrasound‐Responsive Macrophage Biomimetic Phase‐Change Nanoparticles for Delivering miR‐126 Ameliorate Murine Heart Transplant Rejection. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505516

BibTeX
@article{Yang2026,
  author = {Yang, Haichao and Yang, Haobo and Liu, Jinhong and Chen, Jianfeng and Liu, Cong and Wang, Jiaxu and Shan, Jiaxin and Xu, Mingyuan and Li, Guangyin and Yao, Yuan and Tian, Sirui and Zhao, Chen and Zhang, Tiecheng and Yin, Li and Tao, Yangyang and Yu, Dandan and Li, Shouqiang and Wang, Zhuo and Leng, Xiaoping},
  title = {Ultrasound‐Responsive Macrophage Biomimetic Phase‐Change Nanoparticles for Delivering miR‐126 Ameliorate Murine Heart Transplant Rejection},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202505516}
}
Kostenlos starten →